C17 Lactosyl(beta) Ceramide (d18:1/17:0)
| Catalog Number | BL-M001021 |
| CAS Number | 1354699-26-5 |
| Description | C17 Lactosyl(beta) Ceramide (d18:1/17:0) is a paramount molecule frequently employed within the biomedical sphere to investigate its crucial involvement in intricate cell signaling cascades. Moreover, it displays promising prospects for therapeutic interventions targeting neurodegenerative afflictions such as Alzheimer's disease, showcasing its multifaceted utility in advanced research endeavors. |
 | |
| IUPAC Name | N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]heptadecanamide |
| Synonyms | D-Lactosyl-beta-1,1'-N-Heptadecanoyl-D-erythro-Sphingosine; C17 beta-D-Lactosyl Ceramide |
| Molecular Weight | 876.21 |
| Molecular Formula | C47H89NO13 |
| Boiling Point | 995.4±65.0 °C at 760 mmHg |
| Purity | >99% |
| Density | 1.2±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 64.43%, H 10.24%, N 1.60%, O 23.74% |
| Canonical SMILES | CCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C47H89NO13/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-39(52)48-35(36(51)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)34-58-46-44(57)42(55)45(38(33-50)60-46)61-47-43(56)41(54)40(53)37(32-49)59-47/h28,30,35-38,40-47,49-51,53-57H,3-27,29,31-34H2,1-2H3,(H,48,52)/b30-28+/t35-,36+,37+,38+,40-,41-,42+,43+,44+,45+,46+,47-/m0/s1 |
| InChI Key | RXEAEJDDQFAFLW-NMZPIEEZSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
